ClinicalTrials.Veeva

Menu

Registry Study on Rare Cancers in Korea (rarecancer)

Yonsei University logo

Yonsei University

Status

Enrolling

Conditions

Rare Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06746766
4-2024-1207 (Other Identifier)

Details and patient eligibility

About

This study aims to determine the participation rate of patients with registered rare cancers in clinical research.

Full description

Data collection includes:

  • Clinical characteristics (diagnosis, treatment information, primary/metastatic sites, staging, gender/age)
  • Survival information (diagnosis date, recurrence date, death date, disease progression)
  • Pathological information (diagnosis, genomic information)

Enrollment

500 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged ≥19 years
  • Confirmed rare cancer
  • Life expectancy ≥3 months

Exclusion criteria

-Serious or unstable medical/psychiatric conditions

Trial contacts and locations

1

Loading...

Central trial contact

Hyo Song Kim, MD, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems